Stocks in news: Biocon, Nykaa, Britannia, Tata Consumer, Nestle

Biocon has tentative approval from USFDA for Dasatinib Tablets, which are used to treat Philadelphia Chromosome Positive Chronic Myeloid Leukemia.

Subscribe To Our Free Newsletter

All News, Economic Times All News